Abstract
Clinical trials using somatic gene editing (e.g., CRISPR–Cas9) have started in Europe and the United States and may provide safe and effective treatment and cure, not only for cancers but also for some monogenic conditions. In a workshop at the 2018 European Human Genetics Conference, the challenges of bringing somatic gene editing therapies to the clinic were discussed. The regulatory process needs to be considered early in the clinical development pathway to produce the data necessary to support the approval by the European Medicines Agency. The roles and responsibilities for geneticists may include counselling to explain the treatment possibilities and safety interpretation.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Tebas P, Stein D, Tang WW, Frank I, Wang SQ, Lee G, et al. Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. N Engl J Med. 2014;370:901–10.
Dunbar CE, High KA, Joung JK, et al. Gene therapy comes of age. Science. 2018;359:eaan4672.
Committee for Advanced Therapies (CAT). http://www.ema.europa.eu/ema/index.jsp?curl=pages/about_us/general/general_content_000266.jsp&mid=WC0b01ac05800292a4. 2018 Accessed 2 Sept 2018.
Gottlieb S. Remarks by Commissioner Gottlieb to the Alliance for Regenerative Medicine’s Annual Board Meeting. https://www.fda.gov/NewsEvents/Speeches/ucm608445.htm. 2018 Accessed 2 September 2018.
U.S. Food and Drug Administration. Cellular & Gene Therapy Guidances. https://www.fda.gov/biologicsbloodvaccines/guidancecomplianceregulatoryinformation/guidances/cellularandgenetherapy/default.htm. 2018 Accessed 2 September 2018.
European Medicines Agency. Guideline on the quality, non-clinical and clinical aspects of gene therapy medicinal products. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2018/07/WC500252056.pdf. 2018 Accessed 2 September 2018.
World Health Organization. Regional Office for Africa. Sickle cell disease. Fact sheet. https://www.afro.who.int/health-topics/sickle-cell-disease. 2017 Accessed 12 August 2018.
Piel FB, Hay SI, Gupta S, Weatherall DJ, Williams TN. Global burden of sickle cell anaemia in children under five, 2010–2050: modelling based on demographics, excess mortality, and interventions. PLoS Med. 2013;10:e1001484.
Piel FB, Steinberg MH, Rees DC, et al. Sickle cell disease. N Engl J Med. 2017;376:1561–73.
Vakulskas CA, Dever DP, Rettig GR, et al. A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells. Nat Med. 2018;24:1216–24.
Antoniani C, Meneghini V, Lattanzi A, et al. Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human β-globin locus. Blood. 2018;131:1960–73.
National Institutes of Health. Somatic Cell Genome Editing. https://commonfund.nih.gov/editing. 2018 Accessed 12 August 2018.
Gottlieb S. A safety and efficacy study evaluating CTX001 in subjects with transfusion-dependent β-thalassemia. https://clinicaltrials.gov/ct2/show/NCT03655678. 2018 Accessed 29 September 2018.
NIH launches initiative to accelerate genetic therapies to cure sickle cell disease. https://www.nih.gov/news-events/news-releases/nih-launches-initiative-accelerate-genetic-therapies-cure-sickle-cell-disease. 2018 Accessed 29 September 2018.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Cornel, M.C., Howard, H.C., Lim, D. et al. Moving towards a cure in genetics: what is needed to bring somatic gene therapy to the clinic?. Eur J Hum Genet 27, 484–487 (2019). https://doi.org/10.1038/s41431-018-0309-x
Received:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41431-018-0309-x
This article is cited by
-
Genetic therapies for cardiomyopathy: survey of attitudes of the patient community for the CureHeart project
European Journal of Human Genetics (2024)
-
Moving somatic gene editing to the clinic: routes to market access and reimbursement in Europe
European Journal of Human Genetics (2021)
-
How will new genetic technologies, such as gene editing, change reproductive decision-making? Views of high-risk couples
European Journal of Human Genetics (2021)
-
Recent advances in lentiviral vectors for gene therapy
Science China Life Sciences (2021)
-
Gene therapy regulation: could in-body editing fall through the net?
European Journal of Human Genetics (2020)
